Cormorant Asset Management, LP Diversified Active

CIK: 0001583977 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $1,342,487 (100.0% shares, 0.0% debt)

Holdings (42)

MLTX MOONLAKE IMMUNOTHERAPEUTICS 29.9%

Value ($000) $400,924 Shares 8,494,151 Est. Cost $12.22 Unrealized +233.3%

EYPT EYEPOINT PHARMACEUTICALS INC 5.8%

Value ($000) $78,338 Shares 8,325,000 Est. Cost $11.03 Unrealized -37.4%

BBIO BRIDGEBIO PHARMA INC 5.1%

Value ($000) $69,088 Shares 1,600,000 Est. Cost $20.96 Unrealized +73.5%

PRAX PRAXIS PRECISION MEDICINES I 5.1%

Value ($000) $68,331 Shares 1,625,000 Est. Cost $54.23 Unrealized -29.8%

— MERUS N V 4.4%

Value ($000) $58,912 Shares 1,120,000 Est. Cost $48.99 Unrealized —

EWTX EDGEWISE THERAPEUTICS INC 4.2%

Value ($000) $55,744 Shares 4,251,992 Est. Cost $23.73 Unrealized -39.2%

INSM INSMED INC 4.0%

Value ($000) $54,346 Shares 540,000 Est. Cost $37.15 Unrealized +105.8%

ACLX ARCELLX INC 3.9%

Value ($000) $52,680 Shares 800,000 Est. Cost $25.75 Unrealized +141.8%

NAMS NEWAMSTERDAM PHARMA COMPANY 2.9%

Value ($000) $39,389 Shares 2,175,000 Est. Cost $20.31 Unrealized -10.2%

JANX JANUX THERAPEUTICS INC 2.6%

Value ($000) $34,650 Shares 1,500,000 Est. Cost $40.93 Unrealized -35.6%

RAPP RAPPORT THERAPEUTICS INC 2.5%

Value ($000) $33,438 Shares 2,940,921 Est. Cost $23.15 Unrealized -54.2%

— VERONA PHARMA PLC 2.5%

Value ($000) $33,103 Shares 350,000 Est. Cost $94.58 Unrealized —

BBOT HELIX ACQUISITION CORP II 2.3%

Value ($000) $30,894 Shares 2,909,000 Est. Cost $10.35 Unrealized +4.5%

DRUG BRIGHT MINDS BIOSCIENCES INC 2.1%

Value ($000) $27,659 Shares 1,059,331 Est. Cost $35.19 Unrealized -14.8%

CNTA CENTESSA PHARMACEUTICALS PLC 2.0%

Value ($000) $27,418 Shares 2,086,600 Est. Cost $13.13 Unrealized —

PHVS PHARVARIS N V 1.9%

Value ($000) $25,602 Shares 1,454,660 Est. Cost $21.48 Unrealized -25.0%

GHRS GH RESEARCH PLC 1.8%

Value ($000) $24,496 Shares 2,009,482 Est. Cost $13.91 Unrealized -21.2%

SPRY ARS PHARMACEUTICALS INC 1.4%

Value ($000) $19,195 Shares 1,100,000 Est. Cost $12.65 Unrealized +14.1%

CRBP CORBUS PHARMACEUTICALS HLDGS 1.2%

Value ($000) $16,388 Shares 2,375,000 Est. Cost $28.57 Unrealized -74.6%

ABVX ABIVAX SA 1.2%

Value ($000) $16,295 Shares 2,130,000 Est. Cost $10.70 Unrealized —

CGON CG ONCOLOGY INC 1.2%

Value ($000) $16,250 Shares 625,000 Est. Cost $39.73 Unrealized -39.3%

ARQT ARCUTIS BIOTHERAPEUTICS INC 1.0%

Value ($000) $14,020 Shares 1,000,000 Est. Cost $7.71 Unrealized +81.7%

— CARGO THERAPEUTICS INC 1.0%

Value ($000) $13,931 Shares 3,381,277 Est. Cost $10.74 Unrealized —

TARS TARSUS PHARMACEUTICALS INC 0.9%

Value ($000) $12,153 Shares 300,000 Est. Cost $21.36 Unrealized +110.7%

CRNX CRINETICS PHARMACEUTICALS IN 0.9%

Value ($000) $11,504 Shares 400,000 Est. Cost $24.75 Unrealized +24.8%

— METSERA INC 0.8%

Value ($000) $11,380 Shares 400,000 Est. Cost $27.22 Unrealized —

AARD AARDVARK THERAPEUTICS INC 0.8%

Value ($000) $10,819 Shares 800,189 Est. Cost $11.23 Unrealized -8.2%

AXSM AXSOME THERAPEUTICS INC 0.8%

Value ($000) $10,439 Shares 100,000 Est. Cost $74.04 Unrealized +43.0%

BIOA BIOAGE LABS INC 0.7%

Value ($000) $8,841 Shares 2,140,605 Est. Cost $18.97 Unrealized -78.8%

ENGN ENGENE HOLDINGS INC 0.6%

Value ($000) $8,458 Shares 2,323,595 Est. Cost $9.69 Unrealized -61.3%

MBX MBX BIOSCIENCES INC 0.6%

Value ($000) $7,987 Shares 700,000 Est. Cost $22.87 Unrealized -55.5%

CABA CABALETTA BIO INC 0.6%

Value ($000) $7,600 Shares 5,000,000 Est. Cost $1.56 Unrealized 0.0%

ALMS ALUMIS INC 0.5%

Value ($000) $6,442 Shares 2,147,396 Est. Cost $13.30 Unrealized -64.5%

BMEA BIOMEA FUSION INC 0.5%

Value ($000) $6,428 Shares 3,570,872 Est. Cost $17.07 Unrealized -88.7%

KRRO KORRO BIO INC 0.4%

Value ($000) $5,808 Shares 465,000 Est. Cost $26.87 Unrealized -46.4%

PCVX VAXCYTE INC 0.4%

Value ($000) $5,689 Shares 175,000 Est. Cost $53.56 Unrealized -38.8%

RNAM AVIDITY BIOSCIENCES INC 0.4%

Value ($000) $5,680 Shares 200,000 Est. Cost $37.44 Unrealized -20.4%

ELVN ENLIVEN THERAPEUTICS INC 0.3%

Value ($000) $4,012 Shares 200,000 Est. Cost $25.92 Unrealized -27.0%

STOK STOKE THERAPEUTICS INC 0.2%

Value ($000) $2,885 Shares 254,161 Est. Cost $26.85 Unrealized -64.6%

KALA KALA BIO INC 0.2%

Value ($000) $2,870 Shares 603,027 Est. Cost $6.30 Unrealized -38.1%

VYNE VYNE THERAPEUTICS INC 0.2%

Value ($000) $2,262 Shares 1,370,938 Est. Cost $1.30 Unrealized 0.0%

BHVN BIOHAVEN LTD 0.0%

Value ($000) $141 Shares 10,000 Est. Cost $43.60 Unrealized -59.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	8,494,151	$400,924	29.9%	$12.22	+233.3%	CLASS A ORD	61559X104
EYPT	EYEPOINT PHARMACEUTICALS INC	8,325,000	$78,338	5.8%	$11.03	-37.4%	COM NEW	30233G209
BBIO	BRIDGEBIO PHARMA INC	1,600,000	$69,088	5.1%	$20.96	+73.5%	COM	10806X102
PRAX	PRAXIS PRECISION MEDICINES I	1,625,000	$68,331	5.1%	$54.23	-29.8%	COM NEW	74006W207
—	MERUS N V	1,120,000	$58,912	4.4%	$48.99	—	COM	N5749R100
EWTX	EDGEWISE THERAPEUTICS INC	4,251,992	$55,744	4.2%	$23.73	-39.2%	COM	28036F105
INSM	INSMED INC	540,000	$54,346	4.0%	$37.15	+105.8%	COM PAR $.01	457669307
ACLX	ARCELLX INC	800,000	$52,680	3.9%	$25.75	+141.8%	COMMON STOCK	03940C100
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,175,000	$39,389	2.9%	$20.31	-10.2%	ORDINARY SHARES	N62509109
JANX	JANUX THERAPEUTICS INC	1,500,000	$34,650	2.6%	$40.93	-35.6%	COM	47103J105
RAPP	RAPPORT THERAPEUTICS INC	2,940,921	$33,438	2.5%	$23.15	-54.2%	COM	75383L102
—	VERONA PHARMA PLC	350,000	$33,103	2.5%	$94.58	—	SPONSORED ADS	925050106
BBOT	HELIX ACQUISITION CORP II	2,909,000	$30,894	2.3%	$10.35	+4.5%	CL A ORD SHS	G4444H101
DRUG	BRIGHT MINDS BIOSCIENCES INC	1,059,331	$27,659	2.1%	$35.19	-14.8%	COM NEW	10919W405
CNTA	CENTESSA PHARMACEUTICALS PLC	2,086,600	$27,418	2.0%	$13.13	—	SPONSORED ADS	152309100
PHVS	PHARVARIS N V	1,454,660	$25,602	1.9%	$21.48	-25.0%	COM	N69605108
GHRS	GH RESEARCH PLC	2,009,482	$24,496	1.8%	$13.91	-21.2%	ORDINARY SHARES	G3855L106
SPRY	ARS PHARMACEUTICALS INC	1,100,000	$19,195	1.4%	$12.65	+14.1%	COM	82835W108
CRBP	CORBUS PHARMACEUTICALS HLDGS	2,375,000	$16,388	1.2%	$28.57	-74.6%	COM NEW	21833P301
ABVX	ABIVAX SA	2,130,000	$16,295	1.2%	$10.70	—	SPONSORED ADS	00370M103
CGON	CG ONCOLOGY INC	625,000	$16,250	1.2%	$39.73	-39.3%	COM	156944100
ARQT	ARCUTIS BIOTHERAPEUTICS INC	1,000,000	$14,020	1.0%	$7.71	+81.7%	COM	03969K108
—	CARGO THERAPEUTICS INC	3,381,277	$13,931	1.0%	$10.74	—	COM	14179K101
TARS	TARSUS PHARMACEUTICALS INC	300,000	$12,153	0.9%	$21.36	+110.7%	COM	87650L103
CRNX	CRINETICS PHARMACEUTICALS IN	400,000	$11,504	0.9%	$24.75	+24.8%	COM	22663K107
—	METSERA INC	400,000	$11,380	0.8%	$27.22	—	COM	59267L107
AARD	AARDVARK THERAPEUTICS INC	800,189	$10,819	0.8%	$11.23	-8.2%	COM	002942100
AXSM	AXSOME THERAPEUTICS INC	100,000	$10,439	0.8%	$74.04	+43.0%	COM	05464T104
BIOA	BIOAGE LABS INC	2,140,605	$8,841	0.7%	$18.97	-78.8%	COM	09077V100
ENGN	ENGENE HOLDINGS INC	2,323,595	$8,458	0.6%	$9.69	-61.3%	COM	29286M105
MBX	MBX BIOSCIENCES INC	700,000	$7,987	0.6%	$22.87	-55.5%	COM	55287L101
CABA	CABALETTA BIO INC	5,000,000	$7,600	0.6%	$1.56	0.0%	COM	12674W109
ALMS	ALUMIS INC	2,147,396	$6,442	0.5%	$13.30	-64.5%	COM	022307102
BMEA	BIOMEA FUSION INC	3,570,872	$6,428	0.5%	$17.07	-88.7%	COM	09077A106
KRRO	KORRO BIO INC	465,000	$5,808	0.4%	$26.87	-46.4%	COM	500946108
PCVX	VAXCYTE INC	175,000	$5,689	0.4%	$53.56	-38.8%	COM	92243G108
RNAM	AVIDITY BIOSCIENCES INC	200,000	$5,680	0.4%	$37.44	-20.4%	COM	05370A108
ELVN	ENLIVEN THERAPEUTICS INC	200,000	$4,012	0.3%	$25.92	-27.0%	COM	29337E102
STOK	STOKE THERAPEUTICS INC	254,161	$2,885	0.2%	$26.85	-64.6%	COM	86150R107
KALA	KALA BIO INC	603,027	$2,870	0.2%	$6.30	-38.1%	COM NEW	483119202
VYNE	VYNE THERAPEUTICS INC	1,370,938	$2,262	0.2%	$1.30	0.0%	COM	92941V308
BHVN	BIOHAVEN LTD	10,000	$141	0.0%	$43.60	-59.1%	COM	G1110E107